FY25 B2 mayo LD - comp medical AUG 25

On August 1, 2025, the Federal Medical Center Rochester awarded a firm fixed-price purchase order valued at approximately $3.0 million to Mayo Clinic (doing business as Mayo Clinic Specialty Pharmacy) for comprehensive medical services. The contract, which extends through August 31, 2025, represents a mission-critical services engagement without set-aside designation. According to the award documentation, services encompass comprehensive medical support as detailed in the attached Justification for Other Than Full and Open Competition (JOFOC), leveraging Mayo Clinic's established geographic position and medical capabilities in Rochester, Minnesota. The award reflects the Federal Medical Center Rochester's continued reliance on Mayo Clinic as a strategic healthcare partner for specialized clinical support and medical service delivery to federal correctional and medical facilities.

Mayo Clinic's extensive federal contracting history demonstrates its capacity to deliver mission-critical medical services across multiple healthcare domains. The organization maintains a substantial portfolio of firm fixed-price purchase orders with the Bureau of Prisons-operated facilities, typically ranging from $12,000 to $1.4 million per task order, encompassing services such as after-hours physician coverage, telehealth consultations, radiology services, medical consulting, specialized clinical support, medical transportation, and infectious waste management. Beyond correctional healthcare, Mayo Clinic holds significant federal vehicles including a $1.13 million Indefinite Delivery/Indefinite Quantity contract with the Army Reserve Medical Command for medical simulation training services and a $90 million Evidence-based Practice Center program contract with the Agency for Healthcare Research and Quality. As a non-profit academic medical center headquartered in Rochester, Mayo Clinic also maintains an extensive federal research portfolio spanning hundreds of millions of dollars in National Institutes of Health grants across oncology, neurodegenerative disease, cardiovascular research, and metabolic disorder domains.